Horizon Therapeutics Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Horizon Therapeutics Plc
August 03, 2022 15:58 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Horizon Therapeutics plc ("Horizon Therapeutics” or...
Horizon Therapeutics plc Selects AGC Biologics to Further Supply KRYSTEXXA® (pegloticase injection) at AGC’s Copenhagen Facility
April 30, 2021 10:00 ET
|
AGC Biologics
Seattle, April 30, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the expansion of their partnership...